tiprankstipranks
Trending News
More News >
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
US Market

Compare Crinetics Pharmaceuticals (CRNX) vs. Competitors

Compare
758 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Crinetics Pharmaceuticals
$52.96
$5.38B
-11.68
38.62%
12 Buy
0 Hold
0 Sell
Strong Buy
Ligand Pharma
$195.49
$3.90B
94.09
66.69%
7 Buy
0 Hold
0 Sell
Strong Buy
Ultragenyx Pharmaceutical
$24.62
$2.35B
-4.15
-43.10%
17 Buy
1 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$21.81
$2.78B
73.46
-26.79%
11 Buy
6 Hold
0 Sell
Moderate Buy
Kymera Therapeutics
$72.15
$5.61B
-20.06
75.04%
21 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CRNX
Crinetics Pharmaceuticals
52.97
12.71
31.56%
LGND
Ligand Pharma
195.49
76.85
64.78%
RARE
Ultragenyx Pharmaceutical
24.62
-18.78
-43.27%
APLS
Apellis Pharmaceuticals
21.81
-8.58
-28.23%
AKRO
KYMR
Kymera Therapeutics
72.15
31.70
78.37%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts